BOSTON–(BUSINESS WIRE)–“FDNA and Vanderbilt University Medical Center announce integration of FDNA’s Face2Gene suite of applications into the Vanderbilt Center for Undiagnosed Diseases workflow to evaluate difficult-to-diagnose patients in their role as part of the National Institutes of Health (NIH) Undiagnosed Disease Network (UDN).”
Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at the forefront of groundbreaking research into what is now termed Fetal Fentanyl Syndrome—a novel condition observed in children exposed to fentanyl in utero in the context of a maternal opioid use disorder. This emerging syndrome […]